Company profile
Preclinical Neuroscience CRO | Transpharmation
A global leader in translational biology, Transpharmation is the go-to CRO for preclinical neuroscience research.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
MR01 | Transaction MzQzMzM2NTU1N2FkaXF6a2N4
Published 27 Aug 2024 10:44
AA | Transaction MzQzMjYzNDY0OWFkaXF6a2N4
Published 19 Aug 2024 14:27
RESOLUTIONS | Transaction WUQ5MTZMUlNhZGlxemtjeA | Paper/PDF filed
Published 14 Aug 2024 07:55
MA | Transaction MzQzMTY0MzQyNWFkaXF6a2N4 | Paper/PDF filed
Published 14 Aug 2024 07:55
PSC08 | Transaction MzQzMTg4NDI4NmFkaXF6a2N4
Published 12 Aug 2024 19:17
PSC07 | Transaction MzQzMTYzMzk3N2FkaXF6a2N4
Published 08 Aug 2024 15:08
AP01 | Transaction MzQzMTYzMzg2NWFkaXF6a2N4
Published 08 Aug 2024 15:07
Company registered at Companies House
